Nifty
Sensex
:
:
15746.45
52578.76
-78.00 (-0.49%)
-316.65 (-0.60%)

Pharmaceuticals & Drugs - Global

Rating :
42/99

BSE: 506690 | NSE: UNICHEMLAB

339.85
27-Jul-2021
  • Open
  • High
  • Low
  • Previous Close
  •  336.00
  •  344.00
  •  334.50
  •  334.50
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  91299
  •  309.47
  •  375.00
  •  198.05

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 2,353.66
  • 68.57
  • 2
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 2,371.84
  • 1.20%
  • 0.92

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 50.93%
  • 2.62%
  • 30.39%
  • FII
  • DII
  • Others
  • 1.54%
  • 8.45%
  • 6.07%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 3.50
  • -4.32
  • 1.30

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -2.39
  • -12.97
  • -

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -6.95
  • -20.40
  • 83.17

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 16.30
  • 0.63
  • -

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 1.91
  • 1.58
  • 0.59

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 20.14
  • 24.97
  • 33.93

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 21
Mar 20
Var%
Dec 20
Dec 19
Var%
Sep 20
Sep 19
Var%
Jun 20
Jun 19
Var%
Net Sales
274.12
290.20
-5.54%
326.28
274.83
18.72%
317.51
268.14
18.41%
317.27
273.20
16.13%
Expenses
255.07
276.83
-7.86%
296.17
291.99
1.43%
287.65
294.94
-2.47%
305.19
293.42
4.01%
EBITDA
19.05
13.36
42.59%
30.12
-17.16
-
29.86
-26.81
-
12.08
-20.22
-
EBIDTM
6.95%
4.60%
9.23%
-6.24%
9.40%
-10.00%
3.81%
-7.40%
Other Income
7.83
11.82
-33.76%
15.61
25.10
-37.81%
10.04
28.13
-64.31%
16.71
26.26
-36.37%
Interest
1.81
2.40
-24.58%
1.27
2.32
-45.26%
0.79
1.86
-57.53%
1.25
1.28
-2.34%
Depreciation
21.87
22.96
-4.75%
20.82
19.47
6.93%
21.13
20.98
0.71%
20.54
18.25
12.55%
PBT
3.19
-0.17
-
23.64
-13.85
-
17.98
-21.51
-
7.00
-13.49
-
Tax
3.37
17.63
-80.88%
-0.07
1.20
-
9.25
0.68
1,260.29%
4.61
-7.53
-
PAT
-0.17
-17.80
-
23.71
-15.05
-
8.74
-22.19
-
2.39
-5.96
-
PATM
-0.06%
-6.13%
7.27%
-5.48%
2.75%
-8.27%
0.75%
-2.18%
EPS
-0.06
-2.44
-
3.35
-2.07
-
1.24
-3.15
-
0.35
-0.88
-

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Net Sales
-
1,235.14
1,103.71
1,188.19
1,379.90
1,540.06
1,332.65
1,201.79
1,133.45
1,080.80
875.46
Net Sales Growth
-
11.91%
-7.11%
-13.89%
-10.40%
15.56%
10.89%
6.03%
4.87%
23.46%
 
Cost Of Goods Sold
-
302.14
308.63
364.19
274.97
188.77
386.97
378.57
332.84
343.06
278.55
Gross Profit
-
933.00
795.08
823.99
1,104.93
1,351.28
945.67
823.23
800.61
737.75
596.91
GP Margin
-
75.54%
72.04%
69.35%
80.07%
87.74%
70.96%
68.50%
70.63%
68.26%
68.18%
Total Expenditure
-
1,144.03
1,154.53
1,269.21
1,358.21
1,357.62
1,168.77
1,100.79
955.75
910.06
759.42
Power & Fuel Cost
-
68.89
73.02
76.39
49.23
41.62
38.25
39.39
35.97
31.36
26.22
% Of Sales
-
5.58%
6.62%
6.43%
3.57%
2.70%
2.87%
3.28%
3.17%
2.90%
2.99%
Employee Cost
-
306.97
273.28
238.52
200.64
169.04
255.92
223.20
187.37
164.88
140.06
% Of Sales
-
24.85%
24.76%
20.07%
14.54%
10.98%
19.20%
18.57%
16.53%
15.26%
16.00%
Manufacturing Exp.
-
215.73
232.08
147.23
125.30
103.70
150.54
145.03
137.05
119.15
101.54
% Of Sales
-
17.47%
21.03%
12.39%
9.08%
6.73%
11.30%
12.07%
12.09%
11.02%
11.60%
General & Admin Exp.
-
123.98
147.90
229.37
594.53
744.66
167.66
153.29
127.77
104.73
88.54
% Of Sales
-
10.04%
13.40%
19.30%
43.09%
48.35%
12.58%
12.76%
11.27%
9.69%
10.11%
Selling & Distn. Exp.
-
122.52
116.12
197.24
108.38
107.77
166.84
157.12
134.03
135.93
116.00
% Of Sales
-
9.92%
10.52%
16.60%
7.85%
7.00%
12.52%
13.07%
11.82%
12.58%
13.25%
Miscellaneous Exp.
-
3.81
3.50
16.26
5.16
2.06
2.58
4.19
0.73
10.97
116.00
% Of Sales
-
0.31%
0.32%
1.37%
0.37%
0.13%
0.19%
0.35%
0.06%
1.01%
0.97%
EBITDA
-
91.11
-50.82
-81.02
21.69
182.44
163.88
101.00
177.70
170.74
116.04
EBITDA Margin
-
7.38%
-4.60%
-6.82%
1.57%
11.85%
12.30%
8.40%
15.68%
15.80%
13.25%
Other Income
-
50.19
91.31
98.41
3,278.19
5.50
19.11
20.72
42.38
16.96
12.50
Interest
-
5.12
7.85
7.52
8.01
3.36
2.90
3.04
3.19
3.29
4.08
Depreciation
-
84.36
81.67
67.37
50.51
43.52
38.79
41.27
45.72
38.34
30.43
PBT
-
51.82
-49.02
-57.50
3,241.36
141.07
141.31
77.41
171.17
146.07
94.03
Tax
-
17.15
11.97
-33.64
696.23
32.58
29.30
2.13
43.00
32.85
22.77
Tax Rate
-
33.10%
-24.42%
58.50%
21.48%
23.09%
21.27%
2.75%
25.12%
22.49%
24.22%
PAT
-
34.67
-61.00
-23.87
2,545.13
108.49
108.48
75.28
128.16
113.23
71.26
PAT before Minority Interest
-
34.67
-61.00
-23.87
2,545.13
108.49
108.48
75.28
128.16
113.23
71.26
Minority Interest
-
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
PAT Margin
-
2.81%
-5.53%
-2.01%
184.44%
7.04%
8.14%
6.26%
11.31%
10.48%
8.14%
PAT Growth
-
-
-
-
2,245.96%
0.01%
44.10%
-41.26%
13.19%
58.90%
 
EPS
-
4.92
-8.66
-3.39
361.52
15.41
15.41
10.69
18.20
16.08
10.12

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Shareholder's Funds
2,556.83
2,531.35
2,619.91
2,680.08
1,063.62
954.33
867.52
816.61
727.07
660.58
Share Capital
14.08
14.08
14.08
14.07
18.18
18.17
18.15
18.13
18.09
18.06
Total Reserves
2,535.00
2,512.44
2,601.99
2,665.42
1,044.00
935.01
848.52
797.74
707.98
641.80
Non-Current Liabilities
49.16
43.72
10.10
46.46
64.49
76.02
74.21
97.72
94.31
92.67
Secured Loans
0.00
0.00
0.00
0.33
0.44
22.98
20.35
24.65
20.89
20.47
Unsecured Loans
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
23.49
Long Term Provisions
30.41
23.51
14.60
10.76
25.33
12.58
8.88
7.64
9.19
10.24
Current Liabilities
505.76
566.73
502.92
463.51
392.62
275.09
211.76
230.32
251.12
233.30
Trade Payables
210.08
250.22
221.41
226.23
210.73
163.95
138.23
150.52
156.63
140.30
Other Current Liabilities
176.97
122.04
68.45
63.03
68.01
60.56
45.86
32.99
36.65
34.28
Short Term Borrowings
100.63
184.03
199.67
150.29
97.62
12.93
1.63
1.04
6.17
25.42
Short Term Provisions
18.09
10.44
13.39
23.97
16.25
37.65
26.05
45.78
51.67
33.30
Total Liabilities
3,111.75
3,141.80
3,132.93
3,190.05
1,520.73
1,305.44
1,153.49
1,144.65
1,072.50
986.55
Net Block
880.42
866.06
806.29
574.45
487.22
402.60
415.99
419.29
447.76
408.39
Gross Block
1,193.56
1,098.27
975.96
689.74
561.37
439.53
724.65
688.25
675.87
599.27
Accumulated Depreciation
313.14
232.21
169.67
115.29
74.15
36.92
308.66
268.96
228.11
190.87
Non Current Assets
1,734.44
1,455.33
1,093.64
853.59
772.27
673.34
589.07
563.97
594.06
547.20
Capital Work in Progress
567.50
330.47
92.39
238.15
249.98
237.13
122.64
90.54
132.20
112.76
Non Current Investment
159.12
134.38
129.20
9.20
9.51
5.54
5.83
5.72
5.72
0.03
Long Term Loans & Adv.
112.89
112.90
56.37
24.05
25.57
28.05
44.61
48.42
8.38
26.02
Other Non Current Assets
14.52
11.52
9.39
7.74
0.00
0.00
0.00
0.00
0.00
0.00
Current Assets
1,377.32
1,686.47
2,039.29
2,336.47
748.46
632.11
564.42
580.68
478.44
439.35
Current Investments
236.43
419.10
800.75
895.55
8.00
8.04
35.04
5.67
33.06
14.50
Inventories
538.34
396.54
338.66
272.86
281.71
230.57
207.68
203.49
143.05
157.96
Sundry Debtors
250.27
390.14
436.05
276.92
315.32
220.09
191.58
196.51
206.95
183.25
Cash & Bank
82.45
233.81
200.99
681.46
16.14
20.13
26.96
52.15
24.64
23.23
Other Current Assets
269.83
63.84
68.65
64.17
127.29
153.28
103.17
122.86
70.75
60.40
Short Term Loans & Adv.
207.62
183.04
194.18
145.51
98.80
122.77
82.25
105.67
61.73
53.14
Net Current Assets
871.56
1,119.74
1,536.37
1,872.95
355.84
357.02
352.66
350.36
227.32
206.05
Total Assets
3,111.76
3,141.80
3,132.93
3,190.06
1,520.73
1,305.45
1,153.49
1,144.65
1,072.50
986.55

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Cash From Operating Activity
33.10
19.82
-327.77
-112.34
68.19
111.91
78.10
86.73
171.23
124.08
PBT
51.48
-48.21
-57.44
3,241.14
141.25
137.68
77.41
171.17
146.07
94.03
Adjustment
65.65
18.79
6.80
-3,207.66
53.31
39.65
35.57
18.74
47.15
39.37
Changes in Working Capital
-69.67
53.58
-264.94
-146.67
-98.65
-34.16
-16.49
-66.32
13.05
13.51
Cash after chg. in Working capital
47.46
24.15
-315.57
-113.20
95.91
143.16
96.49
123.58
206.27
146.91
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-14.36
-4.34
-12.20
0.86
-27.72
-31.25
-18.39
-36.85
-35.04
-22.83
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-73.56
-35.91
-286.01
1,648.33
-127.87
-85.33
-52.34
35.70
-118.45
-101.80
Net Fixed Assets
-328.53
-338.73
-139.02
-107.71
-135.60
154.89
-73.58
38.14
-92.98
-106.47
Net Investments
147.92
374.24
-63.59
-889.36
17.40
42.09
-32.73
20.34
-34.14
-5.98
Others
107.05
-71.42
-83.40
2,645.40
-9.67
-282.31
53.97
-22.78
8.67
10.65
Cash from Financing Activity
-121.19
-62.30
-2.42
-881.13
59.23
-33.42
-50.95
-94.92
-51.38
-14.21
Net Cash Inflow / Outflow
-161.65
-78.40
-616.19
654.86
-0.46
-6.84
-25.19
27.51
1.41
8.07
Opening Cash & Equivalents
231.52
197.05
666.07
11.21
11.67
26.96
52.15
24.64
23.23
15.16
Closing Cash & Equivalent
77.46
231.52
197.05
666.07
11.21
20.13
26.96
52.15
24.64
23.23

Financial Ratios

Consolidated /

Standalone
Description
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Book Value (Rs.)
362.05
358.85
371.69
380.95
116.88
104.93
95.48
90.02
80.27
73.06
ROA
1.11%
-1.94%
-0.75%
108.06%
7.68%
8.82%
6.55%
11.56%
11.00%
7.63%
ROE
1.37%
-2.37%
-0.90%
136.04%
10.77%
11.92%
8.95%
16.62%
16.34%
11.16%
ROCE
2.12%
-1.49%
-1.77%
162.77%
13.42%
14.97%
9.29%
21.84%
20.13%
14.03%
Fixed Asset Turnover
1.08
1.06
1.43
2.21
3.08
2.32
1.71
1.67
1.71
1.55
Receivable days
94.63
136.61
109.51
78.30
63.41
55.72
58.55
64.53
65.42
76.34
Inventory Days
138.14
121.57
93.93
73.33
60.67
59.32
62.03
55.42
50.47
63.88
Payable days
70.25
76.39
73.41
94.97
104.25
52.00
52.61
62.52
65.77
65.64
Cash Conversion Cycle
162.51
181.78
130.03
56.65
19.82
63.05
67.97
57.43
50.11
74.58
Total Debt/Equity
0.04
0.07
0.08
0.06
0.09
0.04
0.03
0.03
0.04
0.11
Interest Cover
11.12
-5.25
-6.64
405.79
43.00
48.57
26.45
54.66
45.40
24.06

News Update:


  • Unichem Laboratories gets tentative approval for Sitagliptin Tablets
    12th Jul 2021, 10:57 AM

    The company has received tentative approval from the United States Food and Drug Administration

    Read More
  • Unichem Laboratories gets USFDA’s tentative nod for Aripiprazole Tablets
    1st Jul 2021, 10:32 AM

    Product will be commercialized from Unichem’s Ghaziabad Plant on receipt of full approval

    Read More
  • Unichem Laboratories gets ANDA approval for Amitriptyline HCl Tablets
    20th May 2021, 14:50 PM

    The product will be commercialized from Unichem’s Goa Plant

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.